PERPHENAZINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Perphenazine, and when can generic versions of Perphenazine launch?
Perphenazine is a drug marketed by Pharm Assoc, Ani Pharms, Appco, Endo Operations, Macleods Pharms Ltd, Mylan, Rising, Sandoz, Watson Labs Inc, Wilshire Pharms Inc, Zydus Pharms, Chartwell Rx, Fosun Pharma, Ivax Sub Teva Pharms, Par Pharm, Sun Pharm Industries, and Watson Labs. and is included in forty-nine NDAs.
The generic ingredient in PERPHENAZINE is amitriptyline hydrochloride; perphenazine. There are thirteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amitriptyline hydrochloride; perphenazine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PERPHENAZINE?
- What are the global sales for PERPHENAZINE?
- What is Average Wholesale Price for PERPHENAZINE?
Summary for PERPHENAZINE
| US Patents: | 0 |
| Applicants: | 17 |
| NDAs: | 49 |
| Finished Product Suppliers / Packagers: | 16 |
| Raw Ingredient (Bulk) Api Vendors: | 117 |
| Clinical Trials: | 27 |
| Patent Applications: | 4,191 |
| Drug Prices: | Drug price information for PERPHENAZINE |
| DailyMed Link: | PERPHENAZINE at DailyMed |
Recent Clinical Trials for PERPHENAZINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Institute of Experimental and Clinical Therapeutics | Phase 2 |
| Hospital Civil de Guadalajara | Phase 2 |
| University of Guadalajara | Phase 2 |
Pharmacology for PERPHENAZINE
| Drug Class | Phenothiazine |
Medical Subject Heading (MeSH) Categories for PERPHENAZINE
Anatomical Therapeutic Chemical (ATC) Classes for PERPHENAZINE
US Patents and Regulatory Information for PERPHENAZINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE | amitriptyline hydrochloride; perphenazine | TABLET;ORAL | 070375-001 | Aug 25, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Zydus Pharms | PERPHENAZINE | perphenazine | TABLET;ORAL | 205232-004 | Apr 6, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Watson Labs Inc | PERPHENAZINE | perphenazine | TABLET;ORAL | 207582-003 | Oct 17, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
